Literature DB >> 8489206

Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease.

W P Gai1, L B Geffen, L Denoroy, W W Blessing.   

Abstract

We used immunohistochemical analysis to determine whether medulla oblongata neurons containing phenylethanolamine N-methyltransferase (PNMT) are affected in patients who died with idiopathic Parkinson's disease (n = 7) compared with age-matched control subjects who died with nonneurological diseases (n = 8). Transverse sections (50 microns) of medulla were prepared either for conventional neuropathological examination or for the immunohistochemical demonstration of PNMT. Immunopositive neurons at approximately 30 rostrocaudal levels, evenly spaced throughout the whole medulla, were mapped and cells in each section were counted with a camera lucida system linked to a computer. In the ventrolateral medulla, from the level of the obex to 11 mm rostral to the obex where the C1 group of neurons is located, there were 7,631 +/- 844 PNMT-positive neurons in control brains and 3,604 +/- 1,051 in brains affected by Parkinson's disease (47% of control). Many PNMT-positive neurons contained Lewy bodies. We observed a previously undescribed midline (C3) group of PNMT-positive neurons in normal brains, and this group was also severely affected (12% of control) in parkinsonian brains. Neither the C2 group nor the small PNMT-positive neurons in the nucleus tractus solitarii were significantly reduced in numbers but there was a reduction in the numbers of melanin-pigmented cells in both the ventrolateral (50% of control) and the dorsomedial (79% of control) region. Our results demonstrate a selective loss of C1 and C3 PNMT-positive neurons, providing the first quantitative evidence for damage to these presumed brainstem sympathetic premotor neurons in Parkinson's disease. These changes may underlie some of the autonomic symptoms occurring in this condition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489206     DOI: 10.1002/ana.410330405

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction.

Authors:  E B Andersen; F Boesen
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

2.  Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.

Authors:  W P Gai; J C Vickers; P C Blumbergs; W W Blessing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

Review 3.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

4.  Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.

Authors:  S Apparsundaram; K R Moore; M D Malone; H C Hartzell; R D Blakely
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

5.  Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.

Authors:  A Churchyard; C J Mathias; P Boonkongchuen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

6.  Neuropeptide Y innervation of nitric oxide-synthesizing sympathetic preganglionic neurons in humans.

Authors:  E E Benarroch; I L Smithson
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

Review 7.  Brainstem in multiple system atrophy: clinicopathological correlations.

Authors:  Eduardo E Benarroch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

8.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

9.  The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion.

Authors:  John Smythies; Angela De Iuliis; Lucia Zanatta; Lauro Galzigna
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

10.  The adrenochrome hypothesis of schizophrenia revisited.

Authors:  John Smythies
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.